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A B S T R A C T
Background: Short- and long-term spatiotemporal variation in exposure to air pollution is associated with re-
spiratory morbidity in areas with moderate-to-high level of air pollution, but very few studies have examined
whether these associations also exist in areas with low level exposure.
Objectives: We assessed the association between spatial variation in long-term exposure to PM2.5 and NO2 and
hospitalisation for all respiratory diseases, asthma, chronic obstructive pulmonary disease (COPD), and pneu-
monia, in older adults residing in Sydney, Australia, a city with low-level concentrations.
Methods: We recorded data on hospitalisations for 100,084 participants, who were aged> 45 years at entry in
2006–2009 until June 2014. Annual NO2 and PM2.5 concentrations were estimated for the participants' re-
sidential addresses and Cox proportional hazards regression was used to model the association between exposure
to air pollutants and ﬁrst episode of hospitalisation, controlling for personal and area level covariates. We further
investigated the shape of the exposure-response association and potential eﬀect modiﬁcation by age, sex, edu-
cation level, smoking status, and BMI.
Results: NO2 and PM2.5 annual mean exposure estimates were 17.5 μg·m−3 and 4.5 μg·m−3 respectively. NO2
and PM2.5 was positively, although not signiﬁcantly, associated with asthma. The adjusted hazard ratio for a
1 μg·m−3 increase in PM2.5 was 1.08, 95% conﬁdence interval 0.89–1.30. The adjusted hazard ratio for a
5 μg·m−3 increase in NO2 was 1.03, 95% conﬁdence interval 0.88–1.19. We found no positive statistically sig-
niﬁcant associations with hospitalisation for all respiratory diseases, and pneumonia while negative associations
were observed with COPD.
Conclusions: We found weak positive associations of exposure to air pollution with hospitalisation for asthma
while there was no evidence of an association for all respiratory diseases.
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1. Introduction
Epidemiological studies consistently ﬁnd associations between
short-term temporal variation and long-term spatial variation in ex-
posure to air pollution and mortality or morbidity (WHO 2013).
Globally, ambient particulate matter pollution was the ﬁfth-ranking
risk factor for premature death in 2015. Exposure to particulate matter
(PM) with aerodynamic diameter< 2.5 μm (PM2.5) was estimated to
cause 4.2 million premature deaths representing 7.6% of total global
premature deaths (Cohen et al. 2017).
Over the last decades, ambient air pollutant concentrations have
decreased signiﬁcantly in developed countries (Brauer et al. 2016).
Nevertheless, an epidemiological study found adverse health eﬀects of
exposure to air pollution at levels well below current WHO air pollution
standards (Crouse et al. 2012). To date, due to the very limited number
of epidemiological studies of long term exposure to air pollution at low
concentrations, little evidence is available on whether there is any
speciﬁc threshold below which the adverse health eﬀects of air pollu-
tion do not occur (Burnett et al. 2014). In order to inform future risk
assessments and regulation, it is important to know whether adverse
eﬀects continue to be observed at lower concentrations of air pollution.
The prevalence of respiratory diseases has signiﬁcantly increased
worldwide (Eder et al. 2006; Gibson et al. 2010; Murray et al. 2013;
Sunyer 2001). In adults, tobacco smoking is established as the main risk
factor, however, the increasing prevalence of respiratory diseases sug-
gests a possible role of environmental factors such as air pollution (Eder
et al. 2006; Kim et al. 2015; Sunyer 2001; WHO 2013). Exposure to air
pollution has adverse acute respiratory eﬀects (Künzli et al. 2010), in-
cluding short-term decreases in lung function, respiratory symptoms,
and increases in hospitalisation and death due to respiratory causes
(Brunekreef and Holgate 2002; Zanobetti et al. 2008). The extent to
which long-term exposure to air pollution contributes to respiratory
disease is less clear (Schikowski et al. 2014b).
A cross-sectional European study of around 650,000 participants
aged ≥20 years (Cai et al. 2017) found that 10 μg·m−3 increases in
nitrogen dioxide (NO2) and particulate matter with aerodynamic dia-
meter< 10 μm (PM10) were associated with 1.9 and 2.8% higher life-
time asthma prevalence respectively. Previous cohort studies have
found associations between long-term exposure to air pollution with
ﬁrst hospitalisation, self-reported diagnosis/symptoms, development
and persistence of asthma and chronic obstructive pulmonary disease
(COPD) in Europe, US, and Australia (Andersen et al. 2011; Andersen
et al. 2012; Bowatte et al. 2018; Fisher et al. 2016; Jacquemin et al.
2015; Young et al. 2014), while others did not observe any associations
(Atkinson et al. 2015; Schikowski et al. 2014a; Weichenthal et al.
2017).
As summarised above, several studies have studied the associations
between exposure to air pollution and respiratory diseases, however,
evidence on the eﬀects of long-term exposure to air pollution on re-
spiratory health is inconsistent. Furthermore, most of these studies have
been conducted in areas with relatively high levels of air pollution, with
mean annual PM2.5 concentrations> 10 μg·m−3, while annual average
PM2.5 in Sydney, Australia's largest city, was around 5.5 μg·m−3 in 2011
(source: New South Wales Government air pollution data).
Despite the need for studies of exposure-response relationships at
lower pollutant concentrations, to our knowledge, there have been very
few studies conducted on the long-term eﬀects of exposure to low-levels
of air pollution on respiratory morbidity. To address this gap in
knowledge we investigated the associations between long-term ex-
posure to low levels of air pollution and hospitalisation for respiratory
diseases in an Australian cohort of adults over 45 years of age.
2. Methods
2.1. Design and health outcome
We obtained data on 266,969 adults aged above 45 years and over,
living in the state of New South Wales (NSW), who were recruited to the
Sax Institute's 45 and Up Study. The prospective participants were
sampled from the Department of Human Services enrolment database.
Each participant joined the study by completing a questionnaire at
baseline (2006–2009) and giving signed consent for follow-up and
linkage of their information to routine health databases. Questionnaire
included information on demographic and social characteristics, per-
sonal health behaviours, and general health-related data (45 and Up
Study Collaborators 2008). The data were linked by the Centre for
Health Record Linkage to hospitalisation data (NSW Admitted Patient
Data Collection) and mortality data (NSW Registry of Births Deaths and
Marriages (RBMD)). Study participants for this analysis comprised
participants who resided in a 100 km×100 km grid centred on Sydney
Airport (Sydney Metropolitan Region), due to availability of pollutant
exposure estimates, resulting in a sample size of 99,317 participants. 45
and Up Study has ethical approval from the University of NSW Human
Research Ethics Committee (HREC) and we have also obtained ethical
approval from University of Sydney HREC for this study.
Only unscheduled hospitalisations were included in the analyses.
Primary diagnosis was used to identify hospitalisation for all respiratory
diseases (International Classiﬁcation of Diseases, 10th revision (ICD-
10): J00–J99 excluding J95.4 to J95.9, R09.1, R09.8), asthma (ICD-10:
J45–J46), COPD (ICD-10: J40–J44), and pneumonia (ICD-10:
J12–J18). Participants with a record of hospitalisation for the same
diagnosis before the baseline were removed from the primary analysis.
The ﬁrst hospitalisation between baseline and 30 June 2014 was de-
ﬁned as the main outcome.
2.2. Exposure assessment
Ambient concentrations of NO2 were estimated using a validated
satellite-based land use regression (LUR) model that has been described
in detail elsewhere (Knibbs et al. 2014; Knibbs et al. 2016). Brieﬂy, the
satellite-based LUR uses satellite observations of NO2 and land-use
variables to predict the annual average NO2. This model explained
around 80% (RMSE=1.4 ppb) of spatial variation in annual ambient
NO2 concentrations during 2006–2011.We used this model to estimate
annual average NO2 concentration at mesh blocks across Sydney in
2007. Mesh blocks are the smallest geographical area deﬁned by Aus-
tralian Bureau of Statistics and contains around 30–60 dwellings. Par-
ticipants' exposure to annual average NO2 in 2007 was calculated at the
mesh block centroid closest to their residential addresses.
Ambient PM2.5 concentrations were estimated using a chemical
transport model blended with ﬁxed site monitor data (Physick et al.
2007). Using elliptical inﬂuence functions, this model blends computed
air pollutant ﬁelds from a meteorological and air quality model with
observations from the air quality network. This model estimated the
07/2010–07/2011 annual average PM2.5 concentrations across Sydney
at 1 km2 resolution and has been described elsewhere (Broome et al.
2016). Estimated PM2.5 and NO2 concentrations were assumed to re-
ﬂect the concentrations at baseline.
2.3. Statistical analyses
Cox proportional hazards models were used to assess the association
between exposure to NO2 and PM2.5 and ﬁrst hospitalisation for re-
spiratory disease. Age was treated as underlying time and was left
truncated at the age at recruitment and right censored at the ﬁrst ad-
mission post recruitment, death or end of follow-up (30 June 2014),
whichever came ﬁrst. Following an approach similar to the ESCAPE
study (Beelen et al. 2014), the eﬀects of exposure to NO2 and PM2.5
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were adjusted for deﬁned confounders, determined a priori, in three
steps: Model 1) age (underlying time in years), sex and year of enrol-
ment (continuous in years); Model 2) Model 1 plus adjustment for
marital status (categorical variable: married/partnered or single/di-
vorced/widowed), education (categorical variable: below high school,
high school or university), employment status (categorical variable:
employed or unemployed/retired), smoking status (categorical vari-
able: current, previous or non-smoker), smoking duration (for current/
past smokers in years), smoking intensity (for current smokers in cigs/
day) and body mass index (BMI) (categorical variable: underweight
(BMI < 18.5 kg/m2), normal (18.5 kg/m2 < BMI < 25 kg/m2),
overweight (25 kg/m2 < BMI < 30 kg/m2), obese (BMI > 30 kg/
m2); Model 3 (Main model) Model 2 plus further adjustment for area
level socioeconomic status (SES) indicator. All models (1–3) were per-
formed using the dataset with no missing covariates in model 3.
We used the Index of Relative Socioeconomic Disadvantage (IRSD)
from the 2006 Census as the measure of area level SES. This index
summarises a range of information (e.g. income, education, and un-
employment) for individuals and households within a Census Collection
District (CCD), the smallest geographical spatial unit, with on average
220 dwellings in urban areas (ABS 2006). Low score indicates relatively
greater disadvantage (ABS 2008). We ranked the IRSD score in Sydney
Metropolitan Region and grouped these into quartiles where category 1
(lower SES) is the most disadvantaged and category 4 (higher SES) is
the least disadvantaged.
All models were tested for proportional hazard assumptions. To
allow comparison across pollutants and ease of comparison with other
studies, the eﬀects of exposure to PM2.5 and NO2 were estimated for
either 1, 5, or 10 μg·m−3 changes in each pollutant, whichever was
closest to the interquartile range (IQR). When the model 3 (main
model) results suggested an association with air pollution we further
examined the exposure-response relation using splines and threshold
modelling. A 3rd degree penalised p-spline (Eilers and Marx 1996) was
used to estimate non-linear associations. Optimal number of degrees of
freedom for the splines was chosen based on corrected Akaike In-
formation Criterion (AIC) (Hurvich et al. 1998). Signiﬁcance of non-
linear trends was assessed by the likelihood ratio test. Model 3 s were
also developed with PM2.5 and NO2 eﬀect assumed null below certain
threshold levels. Thresholds ranged from 1 μg·m−3 and increased by a
step of 1 μg·m−3 to the 90th percentile. Performances of threshold
models were assessed by any decrease in the AIC and Bayesian In-
formation Criterion (BIC). Potential eﬀect modiﬁcation by age group
(< 60 years, 60–74 years,> 75 years), sex, education level, smoking
status, and BMI category was evaluated by introducing interaction term
in the main model. These covariates have been identiﬁed as potential
eﬀect modiﬁers (Beelen et al. 2014; Stafoggia et al. 2014).
We also applied several sensitivity analyses to test the robustness of
our eﬀect estimates 1) Model 3 was further adjusted for additional
covariates including physical activity and alcohol consumption; 2) as
participants residing in the same area may share similar characteristics
and exposure to similar environmental conditions, we applied multi-
level random eﬀects (frailty) models to account for the potential spatial
correlation. Random eﬀects in our models were represented by one
level of spatial cluster deﬁned by Statistical Area Level 2 (SA2). SA2s
have an average population of about 10,000 persons; 3) we also applied
frailty models by including area level SES as a random eﬀect; 4) since
some individuals may have repeat admissions, we included multiple
admissions for individuals in a negative binomial regression model with
each person-year at risk as the denominator; 5) participants with a
record of hospitalisation for the same diagnosis before the baseline
were included in the analysis; 6) since COPD is sometimes mis-
diagnosed as asthma and vice versa, we combined these two outcomes
in the analysis; 6) participants with a self-reported asthma diagnosis at
baseline were analysed separately. Covariates of the model 3 were in-
cluded in all the sensitivity models.
The results are presented as Hazard Ratios (HRs) with 95%
conﬁdence intervals (CIs) per 1 and 5 μg·m−3 increase in NO2 and PM2.5
concentrations, respectively, using Survival package version 2.38–1 in
R version 3.2.0.
3. Results
Of the 99,317 cohort participants who resided in the Sydney
Metropolitan Region, 12,870 were excluded due to missing information
on covariates and/or exposure estimates and 2162 had an admission for
respiratory diseases before baseline. Of the 84,285 (85%) remaining
participants, 3530 were hospitalised for the ﬁrst time post-baseline for
respiratory diseases (Table 1).
Average pollutant concentrations were 17.5 μg·m−3 for NO2 and
4.5 μg·m−3 for PM2.5 (Table 2). Areas with a lower SES were associated
with higher concentrations for both NO2 and PM2.5. Annual con-
centrations of PM2.5 were strongly correlated with NO2 (r=0.8).
The prevalence of hospitalisation on one or more occasions during
the study period due to respiratory diseases increased with age and with
decreasing area-level and individual SES characteristics (Table 3). It
was greater in men than women and in underweight and obese in-
dividuals, compared with normal weight individuals.
The associations between 1 and 5 μg·m−3 increase in PM2.5 and NO2
concentrations, respectively, and time to ﬁrst hospitalisations are
shown in Table 4. All models satisﬁed the proportional hazards as-
sumption test. Exposure to PM2.5 and NO2 displayed positive but not
statistically signiﬁcant associations with hospitalisation for asthma
(HRs and 95% CIs: 1.10 (0.89–1.37), and 1.03 (0.88–1.19) for PM2.5
and NO2, respectively). Exposure to PM2.5 and NO2 was negatively
associated with hospitalisation for COPD (HRs and 95% CIs: 0.89
(0.79–1.01), and 0.90 (0.82–0.98) for PM2.5 and NO2, respectively). No
associations were observed for all respiratory diseases and pneumonia.
Inclusion of area level SES in all the models attenuated the estimated
HRs.
Application of the frailty models as well as negative binomial model
did not signiﬁcantly alter the eﬀect estimates (Table S1, 4 and7).
Table 1
Number of hospitalisations pre- and post-baseline for diﬀerent respiratory
outcomes, 45 and Up cohort.
Outcome Pre-baseline
hospitalisation
First post-baseline
hospitalisation
All respiratory diseases 2162 3530
Asthma 900 218
COPD 467 748
Pneumonia 940 1762
Table 2
Summary of assigned NO2 (2007) and PM2.5 (2010−11) concentrations esti-
mated in 2007 and 2010–2011, respectively, at enrolment for the 45 and Up
study participants residing in the Sydney Metropolitan Region.
PM2.5 (μg·m−3) NO2 (μg·m−3)
Mean (SD) 4.5 (0.6) 17.5 (4.7)
Median (IQR) 4.5 (0.8) 17.0 (5.9)
Minimum 2.8 8.3
Maximum 13.8 71.2
Pollution levels by quartiles of SES
Mean (SD)
1 (most disadvantaged) 4.6 (0.6) 18.3 (4.4)
2 4.5 (0.7) 17.5 (4.9)
3 4.4 (0.6) 17.7 (5.1)
4 (least disadvantaged) 4.4 (0.4) 16.6 (4.0)
Test for pollutant trenda p < 0.001 p < 0.001
Correlationb between pollutants
NO2 0.81 –
a Analysis of variance.
b Spearman's rank correlation coeﬃcient.
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The associations were slightly more positive for all outcomes when
we included the subjects with previous hospitalisations (Table S2), and
more positive associations were observed when we limited the analyses
to individuals with prior asthma hospitalisation (Table S3) which
showed borderline statistical signiﬁcance for the association of ex-
posure to NO2 and hospitalisation for asthma (HR's and 95% CI's: 1.42
(1.00–2.02)). Associations with COPD was no longer negative when we
limited the analyses to individuals with prior COPD hospitalisation
(HRs and 95% CIs: 1.12 (0.89–1.42), and 1.10 (0.93–1.29) for PM2.5
and NO2, respectively).
None of the interaction terms were statistically signiﬁcant. The
nonlinear associations of the exposure-response relationship modelled
by a 3rd degree p-spline with 2 degrees of freedom were not statistically
diﬀerent from linear model. None of the threshold models were
materially diﬀerent from the linear model.
4. Discussion
This is one of the few studies that assesses the eﬀects of long-term
exposure to PM2.5 and NO2 on hospital admission for diﬀerent re-
spiratory diseases at low-level concentrations. We found positive asso-
ciations for asthma while no such associations were found for all re-
spiratory diseases, COPD and pneumonia.
The observed associations of NO2 exposure and asthma hospitali-
sation are generally in agreement with a study conducted in Denmark
with similar NO2 levels (Andersen et al. 2012). Similar to Andersen
et al. (2012), we found higher eﬀects of exposure to air pollution on
asthma hospitalisation for subjects with prior asthma hospitalisation,
compared with those without history of asthma hospitalisation before
baseline. This indicates that air pollution probably aﬀects individual
with severe asthma (as deﬁned by a previous hospitalisation) to a
greater extent compared to people with less severe asthma.
A US study assessed the associations between long-term exposure to
PM2.5 and self-reported asthma diagnosis (Young et al. 2014) and re-
ported an odds ratio (OR) of 1.20 (95% CI: 0.99–1.46) per an IQR in-
crease (3.6 μg·m−3) in PM2.5. A multi-cohort prospective study
(Jacquemin et al. 2015) found a non-signiﬁcant positive association
between PM2.5 and adult-onset asthma (OR and 95% CI per
5 μg.m−3= 1.04 (0.93–1.30)). The magnitude of the associations with
PM2.5 we found in Sydney (HR=1.10 per 1 μg·m−3) with generally
lower PM2.5 concentration (median annual average
PM2.5= 4.5 μg.m−3) was substantially higher than the magnitude
found in the US study (OR=1.20 per 3.6 μg·m−3) and multi-cohort
European study (OR=1.04 per 5 μg·m−3).
In our study, mean pollutant concentrations were 17.5 μg.m−3 for
NO2 and 4.5 μg·m−3 for PM2.5. The median PM2.5 concentration in the
US study (Young et al. 2014) was 10.8 μg·m−3 and in the European
multi-cohort study (Jacquemin et al. 2015), the cohort with the lowest
exposure levels had mean concentrations of 22 μg·m−3 for NO2 and
10 μg·m−3 for PM2.5.
Neupane et al. (2010) found positive associations between exposure
to air pollution and hospitalisation for pneumonia, while we did not
ﬁnd such associations in our study. In contrast to a Danish study
(Andersen et al. 2011) where they found positive associations between
exposure to air pollution and COPD hospitalisation, we found negative
associations which were statistically signiﬁcant for NO2. These incon-
sistent results could be due to higher NO2 mean concentrations in the
study by Neupane et al. (2010) (~30 μg·m−3 vs 17.5 μg·m−3) and
longer follow up period in the study by Andersen et al. (2011)
(~13 years vs ~7 years).
Our results provide some evidence of the eﬀects of exposure to
Table 3
Sample characteristics and hospitalisation percentages of asthma by sex, age,
smoking status, education, employment status, BMI category and socio-eco-
nomic status indicator.
Covariate Category Total (N (%))
84,285
Hospitalisation on one or
more occasions during the
study period for any
respiratory diseases (N
(%)) 3530 (4.2%)
Sex Male 40,276 (47.8%) 1988 (4.9%)
Female 44,009 (52.2%) 1542 (3.5%)
Age-groups
(years)
45–54 27,061 (32.1%) 303 (1.1%)
55–64 27,168 (32.2%) 587 (2.2%)
65–74 15,341 (18.2%) 745 (4.9%)
75–84 11,794 (14.0%) 1352 (11.5%)
> 85 32,918 (3.5%) 543 (18.6%)
Smoking Current 5138 (6.1%) 280 (5.4%)
Previous 27,370 (32.5%) 1455 (5.3%)
Never 51,777 (61.4%) 1795 (3.5%)
Education Below high
school
22,294 (26.5%) 1446 (6.5%)
High school 35,134 (41.7%) 1411 (4.0%)
University 26,857 (31.9%) 673 (2.5%)
Employment
status
Unemployed/
retired
44,333 (53.3%) 2936 (6.6%)
Employed 39,952 (46.7%) 594 (1.5%)
Marital status Single 21,460 (25.5%) 1304 (6.1%)
Married 62,852 (74.5%) 2226 (3.5%)
BMI Underweight 1186 (1.4%) 118 (9.9%)
Normal 34,054(40.4%) 1418 (4.2%)
Overweight 32,595(38.7%) 1280 (3.9%)
Obese 16,450 (19.5%) 714 (4.3%)
Area level SES 1 (lowest SES) 20,902(24.8%) 1238 (5.9%)
2 21,028 (24.9%) 894 (4.3%)
3 21,133 (25.1%) 760 (3.6%)
4 (highest SES) 21,222 (25.2%) 638 (3.0%)
Table 4
Hazard Ratios and 95% Conﬁdence Intervals from Cox Proportional Hazards Models with increasing covariate adjustment for the association between an IQR
increase in PM2.5/NO2 and hospitalisation for respiratory diseases.
Outcome Pollutant Hazard ratios and 95% conﬁdence intervals
Model 1 Model 2 Model 3
All respiratory diseases PM2.5 (μg·m−3) 1.04 (0.98–1.10) 1.02 (0.96–1.08) 0.98 (0.92–1.04)
NO2 (μg·m−3) 1.01 (0.98–1.05) 1.01 (0.97–1.04) 0.99 (0.95–1.03)
Asthma PM2.5 (μg·m−3) 1.16 (0.94–1.44) 1.15 (0.93–1.42) 1.10 (0.89–1.37)
NO2 (μg·m−3) 1.04 (0.90–1.20) 1.05 (0.91–1.22) 1.03 (0.88–1.19)
COPD PM2.5 (μg·m−3) 1.01 (0.89–1.15) 0.94 (0.83–1.06) 0.89 (0.79–1.01)
NO2 (μg·m−3) 0.96 (0.88–1.04) 0.91 (0.84–0.99) 0.90 (0.82–0.98)
Pneumonia PM2.5 (μg·m−3) 1.00 (0.92–1.09) 0.99 (0.91–1.07) 0.96 (0.88–1.05)
NO2 (μg·m−3) 0.99 (0.94–1.05) 0.99 (0.93–1.04) 0.97 (0.92–1.03)
Hazard ratios are for 1 and 5 μg·m−3 changes in PM2.5 and NO2 levels, respectively.
Model 1: adjusted for age (time variable), year of enrolment and sex.
Model 2: model 1 plus marital status, education, employment status, and smoking status/during/intensity, and BMI.
Model 3: model2 plus area level socio-economic status.
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PM2.5 and asthma in lower concentrations. This highlights that more
studies in countries and regions with low-level concentrations should be
conducted in order to further our understanding of the eﬀects of air
pollution at low levels. In addition, our study would help future esti-
mations in the Global Burden of Disease (GBD) study as asthma will be
considered in future updates of GBD estimates (Cohen et al. 2017).
Particulate matter can trigger inﬂammation and induce oxidative
stress (Hogg and Van Eeden 2009). Exposure to particulate matter can
cause bronchial inﬂammatory changes and increased airway resistance
(McCreanor et al. 2007; Salvi et al. 2000). Part of these observed
physiological eﬀects of exposure to particulate matter could perhaps be
short-term, therefore, some asthma hospitalisation observed in our
study could possibly be attributed to the increases of particulate matter
in the days before the admission. Understanding and discerning short-
term exposure eﬀects from long-term exposure eﬀects of air pollution
can help to form a better understanding of the underlying mechanisms.
Therefore, cohort studies analysing simultaneously health eﬀects due to
long-term and short-term exposure to air pollution need to be con-
ducted. We plan to analyse simultaneously long-term and short-term
health eﬀects of exposure to air pollution in future studies. One recent
time series study examined the joint eﬀects of short and long term
exposure to air pollution (Yitshak-Sade et al. 2018), but to our
knowledge, this approach has not yet been implemented in cohort
studies.
It is known that SES is associated with many health outcomes (Adler
and Stewart 2010), in addition, individual and area level SES have both
been found to be associated with air pollution concentrations (Hajat
et al. 2013). In recent studies such as ESCAPE, it has been a common
approach to adjust for area level SES due to potential residual con-
founding. Therefore, we also included the area level SES in our ana-
lyses. We found that this extra adjustment attenuated the HRs esti-
mates. Lower estimates resulted in models including area level SES
(HR=1.10 and 1.03 for PM2.5 and NO2, respectively) compared to the
ones without (HR=1.15 and 1.05 for PM2.5 and NO2, respectively).
Similar attenuating eﬀects of area level SES inclusion have been ob-
served in other studies (Atkinson et al. 2013; Cesaroni et al. 2014). We
found that increasing area level SES was associated with lower levels of
air pollution, therefore, there is a possibility that the adjustment for
area level SES is removing eﬀects of air pollution. Attenuating eﬀects of
area level SES were more pronounced in studies where a composite
measure of socioeconomic status was used (Atkinson et al. 2015)
compared with studies in which a single measure of area level socio-
economic status such as mean income of the neighbourhood were used
(Cesaroni et al. 2014).
This study is a large prospective cohort with detailed individual
level information collected at baseline. Very few studies have in-
vestigated the long-term eﬀects of low-level exposure to PM2.5 and NO2
on respiratory morbidity. This may be due to lack of relevant data
sources (i.e. cohort studies and air pollution exposure estimates) and/or
signiﬁcant costs of these types of studies. However, studies at these low
levels of exposure can help to better understand the exposure-response
relationship at the lower end of the exposure-response curve. This study
was conducted in Sydney, Australia where the level of air pollution is
generally low and the low-level concentrations in Sydney are indicative
of major cities in Australia.
Despite plausible biological mechanisms, the role of ambient air
pollution in the development of respiratory diseases in adults is not
clear due to inconsistencies in the results of epidemiological studies.
Some studies have found positive associations (Andersen et al. 2011;
Andersen et al. 2012; Bowatte et al. 2018; Fisher et al. 2016; Jacquemin
et al. 2015; Young et al. 2014) while others did not observe any asso-
ciations (Atkinson et al. 2015; Schikowski et al. 2014a; Weichenthal
et al. 2017). In addition, studies with hospitalisation or mortality as the
main outcome cannot clearly distinguish the role of air pollution in
exacerbating pre-existing disease from its contribution to the develop-
ment of the disease (Künzli 2012; Schikowski et al. 2014b). Therefore,
whether and to what extent respiratory diseases in adults were caused
or exacerbated by long-term exposure to air pollution is not clear.
A limitation of our study is that it had limited follow up of around
seven years which resulted in a small number of events. The spatial
resolution of PM2.5 was 1 km2 and this may have resulted in exposure
misclassiﬁcation that would likely attenuate the estimated HRs.
Moreover, hospitalisation for respiratory diseases does not represent
the overall prevalence of those diseases, but rather, may only indicate
the prevalence of moderate to severe disease or milder disease in which
the person is at risk of exacerbations.
5. Conclusions
In summary, we found weak positive association between long-term
exposure to ﬁne particulate matter and NO2 with hospitalisation for
asthma in a large Australian cohort at concentrations well below the
current standards. There was no evidence of positive associations for all
respiratory diseases, COPD and pneumonia.
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